Application 021777
- Type
- NDA
- Sponsor
- TEVA PHARMS INTL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 15MG | Yes | No |
| 002 | AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 30MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021777-001 | AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 |
| N021777-002 | AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021777-001 | AB |
| N021777-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021777-001 | AMRIX | 15MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2007-02-01 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021777-002 | AMRIX | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2007-02-01 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021777-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021777-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021777-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021777-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021777-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021777-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021777-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021777-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021777-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021777-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021777-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021777-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021777-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021777-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021777-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021777-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021777-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021777-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021777-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021777-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021777-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021777-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021777-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021777-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021777-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021777-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021777-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N021777-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021777-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021777-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021777-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021777-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021777-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021777-002 | AB | 1 | 782e0a99824c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 7544372 | 2023-11-14 | U-979 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 7790199 | 2023-11-14 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 7820203 | 2023-11-14 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 7829121 | 2023-11-14 | U-1088 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 8877245 | 2023-11-14 | U-979 | 2018-06-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 9375410 | 2023-11-14 | U-1088 | 2016-07-12 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 9399025 | 2023-11-14 | U-979 | Drug product | 2016-08-04 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-001 | 7387793 | 2025-02-26 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 7544372 | 2023-11-14 | U-979 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 7790199 | 2023-11-14 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 7820203 | 2023-11-14 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 7829121 | 2023-11-14 | U-1088 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 8877245 | 2023-11-14 | U-979 | 2018-06-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 9375410 | 2023-11-14 | U-1088 | 2016-07-12 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 9399025 | 2023-11-14 | U-979 | Drug product | 2016-08-04 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021777-002 | 7387793 | 2025-02-26 | Drug product | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 7544372 | 2023-11-14 | U-979 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 7790199 | 2023-11-14 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 7820203 | 2023-11-14 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 7829121 | 2023-11-14 | U-1088 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 8877245 | 2023-11-14 | U-979 | 2018-06-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 9375410 | 2023-11-14 | U-1088 | 2016-07-12 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 9399025 | 2023-11-14 | U-979 | Drug product | 2016-08-04 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-001 | 7387793 | 2025-02-26 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 7544372 | 2023-11-14 | U-979 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 7790199 | 2023-11-14 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 7820203 | 2023-11-14 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 7829121 | 2023-11-14 | U-1088 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 8877245 | 2023-11-14 | U-979 | 2018-06-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 9375410 | 2023-11-14 | U-1088 | 2016-07-12 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 9399025 | 2023-11-14 | U-979 | Drug product | 2016-08-04 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021777-002 | 7387793 | 2025-02-26 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 7544372 | 2023-11-14 | U-979 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 7790199 | 2023-11-14 | Drug product | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 7820203 | 2023-11-14 | Drug product | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 7829121 | 2023-11-14 | U-1088 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 8877245 | 2023-11-14 | U-979 | 2018-06-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 9375410 | 2023-11-14 | U-1088 | 2016-07-12 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 9399025 | 2023-11-14 | U-979 | Drug product | 2016-08-04 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021777-001 | 7387793 | 2025-02-26 | Drug product | 4b0b4de00fa7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 96b650d8-4ad5-42af-aa8c-aa0ac25abfb5 | 2026-03-17 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 30e61110-5bc8-4134-8456-538558479735 | 2025-09-30 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 3175d24d-e8a0-4f14-bed9-a60ad59ac7e7 | 2025-09-26 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 8a8c9479-b3ab-453a-bd8a-deaf38000742 | 2025-09-24 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Doc Rx | d4457b8c-fff8-4c19-8d5a-a667161e5446 | 2025-09-04 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PHOENIX RX LLC | 3a116427-c427-c3bc-e063-6294a90ac539 | 2025-07-21 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | dd546a0e-e5be-4232-8ad8-fcd7d5f9a903 | 2025-05-27 | Warnings, Adverse reactions | 021777 NDA021777 0115-1436 0115-1437 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 2169667d-4f4b-472d-929b-8a0bcbddbe9c | 2025-03-26 | Warnings, Adverse reactions | 021777 NDA021777 63629-8206 |
| Cyclobenzaprine HCL ER | CYCLOBENZAPRINE HCL ER | Direct_Rx | e4a3383a-7b30-25b7-e053-2995a90a341b | 2025-01-22 | Warnings, Adverse reactions | 021777 NDA021777 72189-362 |
| Cyclobenzaprine HCL ER | CYCLOBENZAPRINE HCL ER | Direct_Rx | ed0b9acc-132f-64c0-e053-2995a90a198c | 2025-01-22 | Warnings, Adverse reactions | 021777 NDA021777 72189-389 |
| Cyclobenzaprine HCL ER | CYCLOBENZAPRINE HCL | Advanced Rx Pharmacy of Tennessee, LLC | f8360da5-f1d3-1d89-e053-6294a90ad31c | 2024-12-31 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 259fb05a-4f45-9c8e-e063-6294a90a4484 | 2024-10-29 | Warnings, Adverse reactions | 021777 NDA021777 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ca74d27a-f7c6-462d-a913-1cfa061bd8f3 | 2024-05-31 | Warnings, Adverse reactions | 021777 NDA021777 0093-1921 0093-1920 |
| AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | Cephalon, LLC | 3902123b-1365-ac3c-0934-afff9eeeb1bd | 2024-04-30 | Warnings, Adverse reactions | 021777 NDA021777 63459-701 63459-700 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Impax Generics | NDA AUTHORIZED GENERIC | Current |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Impax Generics | NDA AUTHORIZED GENERIC | Current |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Amneal Pharmaceuticals of New York LLC | NDA AUTHORIZED GENERIC | Current |
| 21695-723 | AMRIX | Cyclobenzaprine Hydrochloride | Rebel Distributors Corp. | NDA | Current |
| 21695-953 | AMRIX | Cyclobenzaprine Hydrochloride | Rebel Distributors Corp | NDA | Current |
| 35356-262 | Amrix | Cyclobenzaprine Hydrochloride | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 50090-1101 | AMRIX | Cyclobenzaprine Hydrochloride | A-S Medication Solutions | NDA | Current |
| 55700-981 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Quality Care Products, LLC | NDA AUTHORIZED GENERIC | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-700 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-701 | AMRIX | Cyclobenzaprine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63629-8206 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | Current |
| 63629-8206 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | Current |
| 72189-362 | Cyclobenzaprine HCL ER | Cyclobenzaprine HCL ER | Direct_Rx | NDA | Current |
| 72189-389 | Cyclobenzaprine HCL ER | Cyclobenzaprine HCL ER | Direct_Rx | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78282 | SUPPL | 2024-04-26 |
| 78280 | SUPPL | 2024-04-26 |
| 58429 | SUPPL | 2019-04-26 |
| 58408 | SUPPL | 2019-04-25 |
| 37627 | SUPPL | 2016-06-01 |
| 28577 | SUPPL | 2016-05-27 |
| 37625 | SUPPL | 2013-06-11 |
| 16355 | SUPPL | 2013-06-11 |
| 6167 | SUPPL | 2013-06-11 |
| 6166 | SUPPL | 2013-06-11 |
| 37626 | SUPPL | 2013-04-16 |
| 6168 | SUPPL | 2013-04-16 |
| 21815 | ORIG | 2008-05-06 |
| 6165 | SUPPL | 2008-03-26 |
| 6164 | ORIG | 2007-02-12 |
| 16354 | ORIG | 2007-02-02 |